Matthew T Campbell

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Matthew T Campbell
Nov 9, 2024, 10:58 | Blog
Pavlos Msaouel: Methodological challenges and solutions in estimating os from Randomized Controlled Trials
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a…
Oct 7, 2024, 07:05 | Insight
Andrew W Hahn: How effective and tolerable is Belzutifan in treating Sporadic Metastatic Clear Cell Renal Cell Carcinoma
Andrew W Hahn, Genitourinary Medical Oncologist, MD Anderson Cancer Center, shared a post on X:…
Sep 20, 2024, 16:11 | Insight
Stefan Maksimović: Our first paper about TKIs and ccRCC in bone and lung!
Stefan Maksimović shared a post by Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at…
Aug 19, 2024, 12:16 | Insight
Talal El Zarif: After adjuvant immunotherapy, what comes next in renal cell carcinoma?
Talal El Zarif shared a post by Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber…
Aug 16, 2024, 14:16 | Insight
Karl Semaan: First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma
Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “Just…
Jul 19, 2024, 14:41 | Blog
DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared a post on X: ''Durable Objective Response to Lurbinectedin in Small Cell…
Apr 11, 2024, 14:28 | Insight
New Paper Alert! Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors
Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors  Authors: Matthew T Campbell,…
All: 7 Posts: 1 - 100
Special Coverage